Our study shows that T cells transduced with TCRs recognizing peptides from the cancer target TdT in the context of allogeneic HLA-A2 efficiently killed TdTposHLA-A2pos patient-derived lymphoblastic leukemia cells of B- and T-cell origin in vitro. This evidence concerns the gene DNTT and cancer.